Rigrodsky & Long, P.A. Announces Investigation Of Cornerstone Therapeutics, Inc. (NASDAQ CM: CRTX) Buyout

  • Do you own shares of Cornerstone Therapeutics, Inc. (NASDAQ CM: CRTX)?
  • Did you purchase any of your shares prior to September 16, 2013?
  • Do you think the proposed buyout price is too low?
  • Do you want to discuss your rights?

If the answer to these questions is "yes," please contact the deal lawyers at Rigrodsky & Long, P.A. ("R & L") today to schedule a FREE consultation. Just call us, or fill out our contact form so that we can call at your convenience. Your consultation will not create any obligation to use our services at any time.

Contact R & L today to be sure your best interests are being protected.

R & L is a national law firm with decades of combined legal experience. R & L is investigating potential claims against the board of directors of Cornerstone Therapeutics, Inc. concerning possible breaches of fiduciary duty and other violations of law related to the Company’s agreement to be acquired by a subsidiary of Chiesi Farmaceutici S.p.A. for $9.50, or approximately $107 million.

Click here to read the full press release.

Rigrodsky & Long, P.A. Announces Investigation Of Cornerstone Therapeutics, Inc. (NASDAQ CM: CRTX) Buyout

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Cornerstone Therapeutics, Inc. (“Cornerstone” or the “Company”) (NASDAQ CM: CRTX) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Chiesi Farmaceutici S.p.A. (“Chiesi”) in a transaction valued at approximately $107 million.  Chiesi currently owns 58% of Cornerstone’s outstanding common shares.

Under the terms of the agreement, public shareholders of Cornerstone will receive $9.50 per share in cash for each share of Cornerstone they own.

The investigation concerns whether Cornerstone’s board of directors failed to adequately shop the Company and obtain the best possible value for Cornerstone’s shareholders before entering into an agreement with Chiesi.  According to Yahoo! Finance, at least one analyst has set a price target for Cornerstone stock at $14.00.

If you own the common stock of Cornerstone and purchased your shares before September 16, 2013, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth Rigrodsky or Shaye Fuchs at Rigrodsky & Long, P.A., 825 East Gate Boulevard, Suite 300, Garden City, New York 11530, by telephone at (888) 969-4242; by e-mail to info@rigrodskylong.com.            

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, on behalf of shareholders in states and federal courts throughout the United States.

Attorney advertising.  Prior results do not guarantee a similar outcome.

R & L, with offices in Delaware and New York, litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.

Attorney advertising.  Prior results do not guarantee a similar outcome.

Learn more about R&L:  Visit Our WebsiteOur Firm  |  Our Practice Areas  |  FAQ's

Fill out the form below or call us toll-free at 888-969-4242, for a FREE no-obligation consultation.